Abstract:The use of an antibiotic may lead to the emergence and spread of bacterial strains resistant to this antibiotic. Experimental and theoretical studies have investigated the drug dose that minimizes the risk of resistance evolution over the course of treatment of an individual, showing that the optimal dose will either be the highest or the lowest drug concentration possible to administer; however, no analytical results exist that help decide between these two extremes. To address this gap, we develop a stochastic mathematical model of bacterial dynamics under antibiotic treatment. We explore various scenarios of density regulation (bacterial density affects cell birth or death rates), and antibiotic modes of action (biostatic or biocidal). We derive analytical results for the survival probability of the resistant subpopulation until the end of treatment, the size of the resistant subpopulation at the end of treatment, the carriage time of the resistant subpopulation until it is replaced by a sensitive one after treatment, and we verify these results with stochastic simulations. We find that the scenario of density regulation and the drug mode of action are important determinants of the survival of a resistant subpopulation. Resistant cells survive best when bacterial competition reduces cell birth and under biocidal antibiotics. Compared to an analogous deterministic model, the population size reached by the resistant type is larger and carriage time is slightly reduced by stochastic loss of resistant cells. Moreover, we obtain an analytical prediction of the antibiotic concentration that maximizes the survival of resistant cells, which may help to decide which drug dosage (not) to administer. Our results are amenable to experimental tests and help link the within and between host scales in epidemiological models. Antibiotic treatment creates a beneficial environment for the evolution of antibiotic-resistant bacterial strains. The dosage of the antibiotic drug during treatment plays an important role during this process. Here, we derive analytical predictions for the survival probability of a resistant subpopulation until the end of treatment with either a biostatic, i.e. growth-inhibiting, or a biocidal, i.e. death-promoting, drug. Importantly, we obtain a prediction for the antibiotic concentration that maximizes this survival probability. Additionally, we also compute the size of the resistant subpopulation at the end of treatment and its carriage time after treatment until it gets outcompeted by an antibiotic-sensitive strain. This post-treatment phase is relevant only for commensal bacteria. We find that treatment with a biocidal drug, compared to a biostatic drug, increases the risk of resistance evolution, results in a larger resistant subpopulation size at the end of treatment and prolongs the carriage time, and therefore shedding, of the resistant strain. Our analytical predictions can be tested experimentally and link the within-host and the population scale of antibiotic resistance dynamics.

Ecological feedback limits the spread of an adaptive β-lactamase mutant

Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change

Enzyme efficiency but not thermostability drives cefotaxime resistance evolution in TEM-1 β-lactamase

When does antimicrobial resistance increase bacterial fitness? Effects of dosing, social interactions, and frequency dependence on the benefits of AmpC β -lactamases in broth, biofilms, and a gut infection model

A stochastic analysis of the interplay between antibiotic dose, mode of action, and bacterial competition in the evolution of antibiotic resistance

Molecular insights into the evolutionary trajectory of a Klebsiella aerogenes clinical isolate with a complex trade-off between resistance and virulence

Coupled environmental and demographic fluctuations shape the evolution of cooperative antimicrobial resistance

Antibiotic dose and nutrient availability differentially drive the evolution of antibiotic resistance and persistence

Low-Level Cefepime Exposure Induces High-Level Resistance in Environmental Bacteria: Molecular Mechanism and Evolutionary Dynamics.

Microbial interactions affect the tempo and mode of antibiotic resistance evolution

Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species

Metabolic fitness landscapes predict the evolution of antibiotic resistance

In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Escherichia coli Resistance Development

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communities

Eco-evolutionary dynamics of cooperative antimicrobial resistance in a population of fluctuating volume and size

Evolvability as a Function of Purifying Selection in TEM-1 β-Lactamase

Rational Design of Antibiotic Treatment Plans

Suppressing evolution through environmental switching

Dynamical Responses Predict a Distal Site that Modulates Activity in an Antibiotic Resistance Enzyme